A team of researchers from Kaunas University of Technology and Lithuanian University of Health Sciences proposed a non-invasive method for detection of melanoma. A patented computer-aided diagnostic system developed by Lithuanian scientists proved to be more than 90% accurate in detecting malignancy in diagnostic images of skin lesions acquired from 100 patients.
In Europe, melanoma is the fifth most common type of cancer and is the major cause of death from skin cancer. Northern Europe displays the largest age-standardised rate mortality of 3.8 per 10,000 in the region, with an incidence of 23.4.
Excision of a primary tumour remains essential in diagnosing melanoma, and the decision for the operation is generally based on the dermatoscopic evaluation of the lesion. However, the accuracy of melanoma clinical diagnosis is only at 65% and strongly relies on the experience of the physician-dermatologist carrying out the analysis.
“The novelty of our method is that it combines diagnostic information obtained from different non-invasive imaging technologies such as optical spectrophotometry and ultrasound. Based on the results of our research, we can confirm that the developed automated system can complement the non-invasive diagnostic methods currently applied in the medical practice by efficiently differentiating melanoma from a melanocytic mole”, says Professor Renaldas Raišutis, head of the team behind the research at Kaunas University of Technology.
In the study, carried out by the researchers of two Lithuanian universities, diagnostic images of skin lesions acquired from 100 different patients were evaluated. By comparing and analysing complex data on skin tumours recorded by different techniques, the researchers were able to develop a novel diagnostic system, differentiating melanoma from a benign nevus with accuracy higher than 90%.
“An efficient diagnosis of an early-stage malignant skin tumour could save critical time: more patients could be examined and more of them could be saved”, says Prof Raišutis.
According to Prof Raišutis, the novel diagnostic system is firstly aimed at medical professionals; he estimates that the price of the final product might be affordable even for smaller medical institutions. However, the team is also thinking about the solutions for individual use at home.
Following the research, the prototype of the technology was developed, and the clinical research is being carried out complying with the requirements of the protocol for the clinical research confirmed by the regional bioethics committee.
The invention was patented in Lithuania (Patent No. LT6670B) and the patent applications filed for Patent Cooperation Treaty and the United States Patent and Trademark Office.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Planned Parenthood stresses importance of cancer screeningon January 25, 2021 at 9:24 am
Cervical cancer is one of the most preventable cancers today. In most cases cervical cancer can be prevented through early detection and treatment.
- Mario Lopez, the American Cancer Society and the National Football League Will Send A Lucky Fan to Super Bowl LVon January 25, 2021 at 9:07 am
The American Cancer Society (ACS), through its Crucial Catch partnership with the National Football League (NFL), announced today that two-time Emmy winner and host of NBC's "Access Hollywood", Mario ...
- New Tool Predicts Chemotherapy Toxicity In Breast Cancer Patientson January 25, 2021 at 7:38 am
In older breast cancer patients, to determine the risk of severe toxicity to chemotherapy a new tool has been developed called Cancer and Aging Research Group- Breast Cancer (CARG-BC) score.
- Planned Parenthood of Wisconsin Reminds Women About Importance of Screening During Cervical Cancer Awareness Month and Beyondon January 25, 2021 at 7:00 am
There was a time when cervical cancer was a leading cause of cancer death in the United States, until the Pap test revolutionized ...
- $ 9.1Bn Worldwide Breast Cancer Diagnostics Market to 2027 with COVID19 Impact Analysis Marketon January 25, 2021 at 6:45 am
Nova One Advisor Recently added a research report The global Breast Cancer Diagnostics market is expected to reach nearly US$ 9.1 Bn by the end of 2027, reflecting a CAGR of 7.7% over the forecast ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- FDA Grants Toripalimab Fast Track Designation for Mucosal Melanomaon January 24, 2021 at 4:21 pm
About Toripalimab Toripalimab was the first domestic anti-PD-1 monoclonal antibody approved for marketing in China. More than thirty company-sponsored clinical studies covering more than fifteen ...
- Frances Abbott husband Sam Loch reveals shocking melanoma diagnosis just weeks after baby newson January 24, 2021 at 3:24 pm
Australian former Olympic rower Sam Loch has revealed how a spot on his shin turned out to be a melanoma just weeks after his wife Frances Abbott announced her pregnancy.
- Cancer vaccine helped keep melanoma under control for years in small studyon January 21, 2021 at 10:47 am
A personalized "cancer vaccine" may help keep a deadly form of skin cancer from growing for years, a small new study in humans suggests. Unlike vaccines that prevent infections, such as measles and ...
- Study: Vaccine protects against melanoma recurrence up to 4 yearson January 21, 2021 at 10:15 am
A custom-made vaccine against melanoma still protects against advanced disease four years after cancer patients receive it, according to a study published Thursday by Nature Medicine.
- Vaccine produces long-lasting anti-tumor response in patients with melanomaon January 21, 2021 at 8:06 am
Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, ...